ES2032205T3 - Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol. - Google Patents
Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol.Info
- Publication number
- ES2032205T3 ES2032205T3 ES198787810646T ES87810646T ES2032205T3 ES 2032205 T3 ES2032205 T3 ES 2032205T3 ES 198787810646 T ES198787810646 T ES 198787810646T ES 87810646 T ES87810646 T ES 87810646T ES 2032205 T3 ES2032205 T3 ES 2032205T3
- Authority
- ES
- Spain
- Prior art keywords
- core
- water
- metoprolol
- administration
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 title abstract 2
- 230000003204 osmotic effect Effects 0.000 title abstract 2
- 229960002237 metoprolol Drugs 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 abstract 1
- 230000003763 resistance to breakage Effects 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93082886A | 1986-11-14 | 1986-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2032205T3 true ES2032205T3 (es) | 1993-01-16 |
Family
ID=25459837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES198787810646T Expired - Lifetime ES2032205T3 (es) | 1986-11-14 | 1987-11-09 | Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0271438B1 (enExample) |
| JP (1) | JP2567427B2 (enExample) |
| KR (1) | KR960002180B1 (enExample) |
| AT (1) | ATE75394T1 (enExample) |
| AU (1) | AU598318B2 (enExample) |
| CA (1) | CA1312016C (enExample) |
| DE (1) | DE3778662D1 (enExample) |
| DK (1) | DK595987A (enExample) |
| ES (1) | ES2032205T3 (enExample) |
| GR (1) | GR3005132T3 (enExample) |
| IE (1) | IE60533B1 (enExample) |
| NZ (1) | NZ222525A (enExample) |
| PT (1) | PT86119B (enExample) |
| ZA (1) | ZA878526B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4892739A (en) * | 1988-04-25 | 1990-01-09 | Ciba-Geigy Corporation | Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties |
| US4859470A (en) * | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
| KR100733925B1 (ko) * | 2005-03-16 | 2007-07-02 | 주식회사 엘지화학 | ＥＣＤ(Ｅｌｅｃｔｒｏ Ｃｈｒｏｍｉｃ Ｄｅｖｉｃｅ) 제어 장치 |
| IL210279A0 (en) | 2009-12-25 | 2011-03-31 | Dexcel Pharma Technologies Ltd | Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
| GB8503666D0 (en) * | 1985-02-13 | 1985-03-13 | Shell Int Research | Producing 4-(2-methoxyethyl)-phenylglycidyl ether |
| US5019302A (en) * | 1986-03-12 | 1991-05-28 | Washington University Technology Associates, Inc. | Method for granulation |
-
1987
- 1987-11-09 ES ES198787810646T patent/ES2032205T3/es not_active Expired - Lifetime
- 1987-11-09 AT AT87810646T patent/ATE75394T1/de active
- 1987-11-09 DE DE8787810646T patent/DE3778662D1/de not_active Expired - Lifetime
- 1987-11-09 EP EP87810646A patent/EP0271438B1/de not_active Expired - Lifetime
- 1987-11-12 NZ NZ222525A patent/NZ222525A/xx unknown
- 1987-11-12 CA CA000551655A patent/CA1312016C/en not_active Expired - Lifetime
- 1987-11-12 PT PT86119A patent/PT86119B/pt not_active IP Right Cessation
- 1987-11-13 KR KR1019870012779A patent/KR960002180B1/ko not_active Expired - Fee Related
- 1987-11-13 AU AU81192/87A patent/AU598318B2/en not_active Ceased
- 1987-11-13 IE IE307187A patent/IE60533B1/en not_active IP Right Cessation
- 1987-11-13 JP JP62285627A patent/JP2567427B2/ja not_active Expired - Lifetime
- 1987-11-13 ZA ZA878526A patent/ZA878526B/xx unknown
- 1987-11-13 DK DK595987A patent/DK595987A/da not_active Application Discontinuation
-
1992
- 1992-07-10 GR GR920400683T patent/GR3005132T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1312016C (en) | 1992-12-29 |
| IE60533B1 (en) | 1994-07-27 |
| DE3778662D1 (de) | 1992-06-04 |
| IE873071L (en) | 1988-05-14 |
| JP2567427B2 (ja) | 1996-12-25 |
| DK595987D0 (da) | 1987-11-13 |
| AU598318B2 (en) | 1990-06-21 |
| JPS63135329A (ja) | 1988-06-07 |
| PT86119B (pt) | 1990-08-31 |
| EP0271438A2 (de) | 1988-06-15 |
| DK595987A (da) | 1988-05-15 |
| KR880005944A (ko) | 1988-07-21 |
| AU8119287A (en) | 1988-05-19 |
| ZA878526B (en) | 1988-05-16 |
| GR3005132T3 (enExample) | 1993-05-24 |
| NZ222525A (en) | 1989-12-21 |
| PT86119A (en) | 1987-12-01 |
| KR960002180B1 (ko) | 1996-02-13 |
| EP0271438A3 (en) | 1989-07-19 |
| EP0271438B1 (de) | 1992-04-29 |
| ATE75394T1 (de) | 1992-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0176724B1 (ko) | 액상 약물 전달용 삼투 투약 시스템 | |
| MX10086A (es) | Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion. | |
| DK1117383T3 (da) | Doseringsformer omfattende terapeutisk formulering | |
| BG85941A (bg) | Лекарствена форма с контролирано освобождаване и метод за получаването й | |
| ES8303091A1 (es) | Un procedimiento para la preparacion de una nueva formulacion de bacampicilina. | |
| KR960009408B1 (en) | Covered sustained-release preparation | |
| DE69020422D1 (de) | Zusammensetzung in Form eines Schaumes enthaltend 5-Aminosalicylic Säure zur intra-rektal Verabreichung. | |
| SE8703034D0 (sv) | Oralt terapeutiskt system med systemisk verkan | |
| BE899464A (fr) | Composition a liberation soutenue de propanolol. | |
| ES2001950A6 (es) | Procedimiento de obtencion de composiciones en emulsion para la administracion de farmacos hidrofobos ionizables escasamente hidrosolubles. | |
| DE3478396D1 (en) | Controlled absorption pharmaceutical formulation | |
| ES2021028B3 (es) | Dispositivo para liberacion de farmacos en 2 etapas. | |
| ES513159A0 (es) | "procedimiento para la preparacion de polipeptidos inmunogenamente activos y producidos microbianamente, para la obtencion de una vacuna contra la fiebre aftosa". | |
| IE882898L (en) | Solubility modulated drug delivery device | |
| ES551674A0 (es) | Procedimiento para la preparacion de liposomas a partir de una mezcla de un componente lipido y agua | |
| IT9019754A1 (it) | Composizioni farmaceutiche, dietetiche o veterinarie ad attivita' eumetabolica | |
| ES2032205T3 (es) | Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol. | |
| JPS574915A (en) | Preparation of medical preparation with long-lasting activity | |
| ES2172332T3 (es) | Utilizacion de soluciones salinas isoosmoticas para la preparacion de medicamentos cerumenoliticos. | |
| DE3215086A1 (de) | Pharmazeutische praeparate | |
| MX9703839A (es) | Soluciones intravenosas de lubeluzol. | |
| SE8106498L (sv) | Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma | |
| ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
| Pojda et al. | The activation of the renin--angiotensin system in the dog after injection of noradrenaline into the lateral brain ventricle | |
| UY24191A1 (es) | Bolo para administrar una sustancia biologicamente beneficiosa a animales rumiantes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 271438 Country of ref document: ES |